- Home
- SYRA vs LGVN Comparison
SYRA vs LGVN Comparison
Compare SYRA & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRA
- LGVN
- Stock Information
- Founded
- SYRA 2020
- LGVN 2014
- Country
- SYRA United States
- LGVN United States
- Employees
- SYRA N/A
- LGVN N/A
- Industry
- SYRA Other Specialty Stores
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- SYRA Industrials
- LGVN Health Care
- Exchange
- SYRA Nasdaq
- LGVN Nasdaq
- Market Cap
- SYRA 7.8M
- LGVN 30.0M
- IPO Year
- SYRA 2023
- LGVN 2021
- Fundamental
- Price
- SYRA $0.42
- LGVN $2.05
- Analyst Decision
- SYRA
- LGVN Strong Buy
- Analyst Count
- SYRA 0
- LGVN 2
- Target Price
- SYRA N/A
- LGVN $8.00
- AVG Volume (30 Days)
- SYRA 122.9K
- LGVN 393.9K
- Earning Date
- SYRA 10-29-2024
- LGVN 11-08-2024
- Dividend Yield
- SYRA N/A
- LGVN N/A
- EPS Growth
- SYRA N/A
- LGVN N/A
- EPS
- SYRA N/A
- LGVN N/A
- Revenue
- SYRA $7,069,566.00
- LGVN $1,229,000.00
- Revenue This Year
- SYRA $42.88
- LGVN $161.78
- Revenue Next Year
- SYRA N/A
- LGVN $8.62
- P/E Ratio
- SYRA N/A
- LGVN N/A
- Revenue Growth
- SYRA 25.18
- LGVN 39.34
- 52 Week Low
- SYRA $0.34
- LGVN $0.77
- 52 Week High
- SYRA $8.37
- LGVN $23.90
- Technical
- Relative Strength Index (RSI)
- SYRA 42.80
- LGVN 52.20
- Support Level
- SYRA $0.35
- LGVN $1.76
- Resistance Level
- SYRA $0.46
- LGVN $2.26
- Average True Range (ATR)
- SYRA 0.03
- LGVN 0.12
- MACD
- SYRA 0.03
- LGVN 0.05
- Stochastic Oscillator
- SYRA 80.28
- LGVN 58.00
About SYRA Syra Health Corp.
Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.